A multicenter cohort study to investigate the factors associated with functional autonomy change in patients with cognitive complaint or neurocognitive disorders: the MEMORA study protocol

• Published in: BMC geriatrics 2019-07, Vol.19 (1), p.191-191, Article 191
• Main Authors: Dauphinot, Virginie, Moutet, Claire, Rouch, Isabelle, Verdurand, Mathieu, Mouchoux, Christelle, Delphin-Combe, Floriane, Gaujard, Sylvain, Krolak-Salmon, Pierre
• Format: Article
• Language: English
• Subjects: Activities of daily living; Activities of Daily Living - psychology; Activity of daily living; Aged; Aged, 80 and over; Alzheimer's disease; Analysis; Cognition - physiology; Cohort Studies; Female; Follow-Up Studies; France - epidemiology; Humans; Life Sciences; Longitudinal study; Male; Medical research; Memory; Memory Disorders - diagnosis; Memory Disorders - epidemiology; Memory Disorders - psychology; Mental disorders; Neurocognitive disorders; Neurocognitive Disorders - diagnosis; Neurocognitive Disorders - epidemiology; Neurocognitive Disorders - psychology; Neurons and Cognition; Neuropsychological Tests; Prospective Studies; Study Protocol
• ISSN: 1471-2318; 1471-2318
• DOI: 10.1186/s12877-019-1204-1

The identification of factors associated with functional impairment, in particular those which are potentially modifiable, may help to delay the advanced stages of functional dependence in patients with neurocognitive disorders such as Alzheimer's disease and related disorders. The objectives of the MEMORA cohort are to investigate the factors associated, first with functional autonomy change over time, and secondarily with the cognitive performance and behavioral disorders changes over time. The MEMORA study is a multicenter prospective cohort study carried out throughout the patient's care pathway, in Memory centers of Lyon (France). The study will include 6780 patients at all stages of memory disorders in 6 years. The follow-up for each patient is planned for 3 years. The main outcome is the functional autonomy level change as assessed by the instrumental abilities of daily living (IADL) score. Patient characteristics include sociodemographic and clinical features, neuropsychological performance, pharmaceutical and non-pharmaceutical therapy. This study conducted in a context of routine care may help to identify the factors associated with functional impairment related to progressive neurocognitive disorders. Subsequently, interventions on potentially modifiable factors could be proposed to the patients to improve their management and delay functional dependence. NCT02302482 , registered 27 November 2014.